Wegovy was recently approved by the FDA to treat weight loss for individuals with a BMI of 30 or higher (considered the obese category) and individuals with an overweight BMI (25 - 30) who also have a weight-related comorbidity (high blood pressure, fatty liver disease, high cholesterol, etc.)
It is a more comprehensive approach that may ultimately produce greater total weight loss, but the timeline still requires patience and consistency
Glutathione is found in virtually every cell of the body and plays a critical role in protein synthesis, enzyme function, transport, and cell maturation*
O'Connell SBL, Gelgoot EN, Grunberg PH, et al
There is no evidence that physical dependence will develop or that discontinuation causes withdrawal symptoms